Arcus Biosciences IncNYSE:RCUS
- LAST PRICE15.3900
- TODAY'S CHANGE (%)-0.0300 (-0.1946%)
- Bid / Lots15.0900/ 1
- Ask / Lots15.8100/ 1
- Open / Previous Close15.5500 / 15.4200
- Day Range
- 52 Week Range
- Volume516,858
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RCUS |
|---|---|---|
| 09:32 ET | 16451 | 15.55 |
| 09:34 ET | 305 | 15.24 |
| 09:38 ET | 200 | 15.3 |
| 09:39 ET | 400 | 15.29 |
| 09:41 ET | 300 | 15.3 |
| 09:43 ET | 200 | 15.26 |
| 09:45 ET | 100 | 15.3 |
| 09:48 ET | 1547 | 15.36 |
| 09:50 ET | 405 | 15.33 |
| 09:52 ET | 100 | 15.37 |
| 09:56 ET | 1631 | 15.26 |
| 09:57 ET | 186 | 15.26 |
| 09:59 ET | 102 | 15.28 |
| 10:01 ET | 405 | 15.31 |
| 10:03 ET | 300 | 15.33 |
| 10:06 ET | 351 | 15.34 |
| 10:08 ET | 357 | 15.3 |
| 10:10 ET | 2067 | 15.36 |
| 10:12 ET | 500 | 15.39 |
| 10:14 ET | 1863 | 15.41 |
| 10:15 ET | 400 | 15.375 |
| 10:17 ET | 840 | 15.355 |
| 10:19 ET | 1254 | 15.36 |
| 10:21 ET | 1661 | 15.38 |
| 10:24 ET | 3410 | 15.416 |
| 10:26 ET | 1110 | 15.385 |
| 10:28 ET | 400 | 15.44 |
| 10:30 ET | 100 | 15.44 |
| 10:32 ET | 467 | 15.45 |
| 10:35 ET | 400 | 15.49 |
| 10:37 ET | 370 | 15.4455 |
| 10:39 ET | 611 | 15.49 |
| 10:42 ET | 100 | 15.5 |
| 10:44 ET | 4237 | 15.555 |
| 10:46 ET | 205 | 15.57 |
| 10:48 ET | 1100 | 15.58 |
| 10:50 ET | 1172 | 15.6 |
| 10:51 ET | 21402 | 15.635 |
| 10:53 ET | 1125 | 15.61 |
| 10:57 ET | 500 | 15.58 |
| 11:00 ET | 1301 | 15.5 |
| 11:02 ET | 1746 | 15.49 |
| 11:06 ET | 1803 | 15.55 |
| 11:08 ET | 51205 | 15.54 |
| 11:09 ET | 4663 | 15.525 |
| 11:13 ET | 1204 | 15.49 |
| 11:15 ET | 2361 | 15.48 |
| 11:18 ET | 2939 | 15.38 |
| 11:20 ET | 900 | 15.39 |
| 11:22 ET | 1462 | 15.34 |
| 11:24 ET | 1240 | 15.275 |
| 11:26 ET | 300 | 15.285 |
| 11:27 ET | 938 | 15.24 |
| 11:29 ET | 2719 | 15.1865 |
| 11:31 ET | 313 | 15.1953 |
| 11:36 ET | 314 | 15.24 |
| 11:38 ET | 610 | 15.26 |
| 11:40 ET | 946 | 15.25 |
| 11:42 ET | 557 | 15.26 |
| 11:44 ET | 100 | 15.265 |
| 11:45 ET | 4717 | 15.19 |
| 11:47 ET | 300 | 15.24 |
| 11:49 ET | 1219 | 15.21 |
| 11:51 ET | 413 | 15.22 |
| 11:54 ET | 400 | 15.23 |
| 11:58 ET | 442 | 15.23 |
| 12:00 ET | 400 | 15.245 |
| 12:02 ET | 2005 | 15.28 |
| 12:03 ET | 500 | 15.31 |
| 12:05 ET | 1323 | 15.27 |
| 12:07 ET | 711 | 15.27 |
| 12:09 ET | 881 | 15.29 |
| 12:12 ET | 500 | 15.29 |
| 12:14 ET | 300 | 15.29 |
| 12:16 ET | 554 | 15.33 |
| 12:18 ET | 684 | 15.295 |
| 12:20 ET | 400 | 15.28 |
| 12:21 ET | 1223 | 15.23 |
| 12:23 ET | 526 | 15.25 |
| 12:25 ET | 800 | 15.31 |
| 12:32 ET | 723 | 15.28 |
| 12:34 ET | 1552 | 15.325 |
| 12:36 ET | 2095 | 15.3 |
| 12:38 ET | 418 | 15.25 |
| 12:39 ET | 500 | 15.28 |
| 12:41 ET | 244 | 15.31 |
| 12:43 ET | 600 | 15.305 |
| 12:45 ET | 200 | 15.28 |
| 12:48 ET | 300 | 15.29 |
| 12:50 ET | 135 | 15.27 |
| 12:52 ET | 1032 | 15.28 |
| 12:54 ET | 431 | 15.3 |
| 12:56 ET | 602 | 15.29 |
| 12:59 ET | 891 | 15.2636 |
| 01:01 ET | 1938 | 15.32 |
| 01:03 ET | 1043 | 15.28 |
| 01:08 ET | 300 | 15.25 |
| 01:12 ET | 600 | 15.22 |
| 01:14 ET | 1115 | 15.215 |
| 01:15 ET | 400 | 15.21 |
| 01:17 ET | 200 | 15.215 |
| 01:21 ET | 1352 | 15.22 |
| 01:26 ET | 595 | 15.23 |
| 01:28 ET | 300 | 15.22 |
| 01:30 ET | 517 | 15.28 |
| 01:32 ET | 1000 | 15.25 |
| 01:33 ET | 200 | 15.26 |
| 01:37 ET | 300 | 15.25 |
| 01:39 ET | 484 | 15.28 |
| 01:42 ET | 200 | 15.29 |
| 01:44 ET | 300 | 15.29 |
| 01:46 ET | 531 | 15.28 |
| 01:48 ET | 312 | 15.29 |
| 01:50 ET | 608 | 15.32 |
| 01:53 ET | 489 | 15.33 |
| 01:55 ET | 282 | 15.33 |
| 01:57 ET | 1495 | 15.33 |
| 02:00 ET | 130 | 15.362 |
| 02:02 ET | 200 | 15.35 |
| 02:04 ET | 102 | 15.38 |
| 02:06 ET | 808 | 15.375 |
| 02:08 ET | 203 | 15.37 |
| 02:09 ET | 200 | 15.36 |
| 02:13 ET | 231 | 15.39 |
| 02:15 ET | 100 | 15.38 |
| 02:18 ET | 257 | 15.39 |
| 02:20 ET | 200 | 15.39 |
| 02:22 ET | 500 | 15.41 |
| 02:24 ET | 27731 | 15.37 |
| 02:26 ET | 100 | 15.355 |
| 02:27 ET | 542 | 15.34 |
| 02:29 ET | 886 | 15.27 |
| 02:31 ET | 304 | 15.27 |
| 02:33 ET | 507 | 15.29 |
| 02:36 ET | 300 | 15.3 |
| 02:38 ET | 700 | 15.32 |
| 02:40 ET | 1216 | 15.29 |
| 02:44 ET | 300 | 15.3 |
| 02:49 ET | 550 | 15.31 |
| 02:51 ET | 1750 | 15.284 |
| 02:54 ET | 3084 | 15.25 |
| 02:56 ET | 100 | 15.26 |
| 02:58 ET | 425 | 15.27 |
| 03:00 ET | 3304 | 15.26 |
| 03:02 ET | 700 | 15.25 |
| 03:03 ET | 100 | 15.26 |
| 03:05 ET | 686 | 15.265 |
| 03:07 ET | 3368 | 15.31 |
| 03:09 ET | 1295 | 15.3 |
| 03:12 ET | 100 | 15.31 |
| 03:14 ET | 321 | 15.31 |
| 03:16 ET | 800 | 15.31 |
| 03:18 ET | 3506 | 15.28 |
| 03:20 ET | 1197 | 15.28 |
| 03:21 ET | 1062 | 15.29 |
| 03:23 ET | 100 | 15.28 |
| 03:25 ET | 100 | 15.28 |
| 03:27 ET | 100 | 15.29 |
| 03:30 ET | 1270 | 15.29 |
| 03:32 ET | 1795 | 15.3 |
| 03:34 ET | 2760 | 15.275 |
| 03:36 ET | 1196 | 15.265 |
| 03:38 ET | 1507 | 15.29 |
| 03:39 ET | 1005 | 15.31 |
| 03:41 ET | 2974 | 15.305 |
| 03:43 ET | 955 | 15.31 |
| 03:45 ET | 2602 | 15.28 |
| 03:48 ET | 1502 | 15.29 |
| 03:50 ET | 1994 | 15.275 |
| 03:52 ET | 1706 | 15.26 |
| 03:54 ET | 4677 | 15.28 |
| 03:56 ET | 3130 | 15.305 |
| 03:57 ET | 6451 | 15.34 |
| 03:59 ET | 129522 | 15.39 |
Yesterday
Sep 24, 2024
Arcus Biosciences Announces New Employment Inducement Grants, from 4:35PM ET on Tuesday Sep 24, 2024 by Dow Jones
4:35PM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 10, 2024
Arcus Biosciences Announces New Employment Inducement Grants, from 4:35PM ET on Tuesday Sep 10, 2024 by Dow Jones
4:35PM ET on Tuesday Sep 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcus Biosciences Inc | 1.4B | -5.0x | --- |
WAVE Life Sciences Ltd | 1.2B | -15.2x | --- |
Ardelyx Inc | 1.6B | -24.9x | --- |
Nurix Therapeutics Inc | 1.4B | -7.5x | --- |
Gyre Therapeutics Inc | 1.1B | -13.7x | --- |
Xencor Inc | 1.4B | -6.7x | --- |
Company Information
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Contact Information
- Headquarters
- 3928 Point Eden WayHAYWARD, CA, United States 94545-3719
- Phone
- 510-694-6200
- Fax
- 302-730-1370
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Terry Rosen
- President, Co-Founder
- Juan Jaen
- Chief Financial Officer
- Robert Goeltz
- Chief Operating Officer
- Jennifer Jarrett
- General Counsel
- Carolyn Tang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.0x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
